Genetics and Genomics
In her Introduction to the special edition of CONQUER titled Understanding Biomarkers & Molecular Testing, Lillie D. Shockney, RN, BS, MAS, ONN-CG, briefly explains what biomarkers are, why they are important, and what you should know about them. Read More ›
One-size-fits-all medicine is a thing of the past. Cancer, at its core, is a genetic disease. Today’s advances in cancer research mean that doctors can now tailor a personalized treatment to the patient’s specific cancer type. Read More ›
Knowing if the patient’s chronic lymphocytic leukemia (CLL) has genetic abnormalities through genetic testing can help doctors select the best treatment. Read More ›
Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer. Read More ›
By Laura Morgan
The terms genetics and genomics are often used interchangeably in relation to cancer, but they refer to different things and are becoming very important in cancer treatment. Read More ›
By Kelsey Moroz
CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success. Read More ›
Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies. Read More ›
Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer. Read More ›
By Dana Taylor
This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts. Read More ›
Multiple myeloma is a type of blood cancer; the cause of this cancer is not yet known. Although it is not considered a hereditary cancer and does not run in families, many genetic factors, especially genetic alterations (mutations) and chromosome abnormalities, play a role in multiple myeloma, as in many other cancers. Read More ›